To make disease-modifying first-in-class immuno-oncology treatments available to patients suffering from devastating conditions such as cancer
Medibiofarma focused internal resources on areas where lies the experience of the management team:
- Virtual drug design
- Medicinal Chemistry
- In Vitro Pharmacology
- Intellectual Property
The remaining activities needed for the full compound characterization and the nomination of a development candidate, such as in vivo pharmacology and toxicology and IND-enabling studies are carried out through partnerships with several companies (CROs), Research Centers and Universities.